February 8, 2022 12:01 PM ESTUpdated February 11, 10:23 AM
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie de­buts Qulip­ta mi­graine TV ads; Lil­ly fo­cus­es on Olympic ath­lete in boy­cotted Games

Beth Snyder Bulik

Senior Editor

Ab­b­Vie launched its first main­stream ad cam­paign for mi­graine pre­ven­tion med Qulip­ta. In two 45-sec­ond TV com­mer­cials, peo­ple are shown staving …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Bio­haven stock sinks on three-month de­lay for neu­ro drug's FDA ap­proval de­ci­sion

Mer­ck KGaA will con­tin­ue to add a tar­iff sur­charge for US cus­tomers 

Hen­grui, one of Chi­na's lead­ing biotechs, an­tic­i­pates $1.2B in pro­posed Hong Kong list­ing

FDA gives Ab­b­Vie ac­cel­er­at­ed ap­proval for an­ti­body-drug con­ju­gate in lung can­cer

RFK Jr. de­fends HHS staff cuts, re­or­ga­ni­za­tion plans in House, Sen­ate hear­ings

Sanofi touts $20B in­vest­ment in US over five years

A service from the Financial Times